Kenneth P. Johnson

Clinical response to glatiramer acetate correlates with modulation of IFN-γ and IL-4 expression in multiple sclerosis

S. Dhib-jalbut, K. Costello, M. Chen, 2007, Multiple sclerosis.

Sustained immunological effects of Glatiramer acetate in patients with multiple sclerosis treated for over 6 years

R. Martin, S. Dhib-jalbut, K. Conway, 2002, Journal of the Neurological Sciences.

A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients

J. Wolinsky, H. Panitch, C. Ford, 2006, Multiple sclerosis.

Reprints and permissions: sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1352458509358088

J. Wolinsky, H. Panitch, A. Goodman, 2022 .